Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison

被引:56
|
作者
Crespo-Facorro, Benedicto [1 ]
Rodriguez-Sanchez, Jose M. [1 ]
Perez-Iglesias, Rocio [1 ]
Mata, Ignacio [1 ]
Ayesa, Rosa [1 ]
Ramirez-Bonilla, MariLuz [1 ]
Martinez-Garcia, Obdulia [1 ]
Vasquez-Barquero, Jose L. [1 ]
机构
[1] Univ Cantabria, Dept Psychiat, CIBERSAM, Sch Med,Univ Hosp Marques Valdecilla, Santander 39008, Spain
关键词
LOW-DOSE HALOPERIDOL; NEUROPSYCHOLOGICAL CHANGE; ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIA; METAANALYSIS; TRIAL; IMPAIRMENT; SCALE;
D O I
10.4088/JCP.08m04634
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: To investigate the neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode schizophrenia-spectrum disorders. Method: This prospective, randomized, open-label study was conducted from February 2001 to February 2005. Data for the present investigation were obtained from a large epidemiologic and 3-year longitudinal intervention program of first-episode psychosis (DSM-IV criteria) conducted at the outpatient clinic and the inpatient unit at the University Hospital Marques de Valdecilla, Santander, Spain. One hundred four patients randomly assigned to haloperidol (N = 35), olanzapine (N = 30), or risperidone (N = 39) who completed clinical and cognitive evaluations at baseline, 6 months, and I year were included in the final analysis. Thirty-seven healthy individuals were also longitudinally assessed. A neuropsychological battery that comprised 9 cognitive domains was used. The contribution of clinical changes, concomitant medications, and the severity of motor side effects to cognitive changes was controlled. The main outcome measure was cognitive changes at 1-year follow-up. Results: The 3 treatment groups showed a significant improvement in cognitive scores after 1 year. The differential cognitive effectiveness between antipsychotics was insignificant. The magnitude of cognitive changes was similar in the 3 treatment groups and controls, although a greater improvement on the Finger Tapping Test, Trail Making Test 13, and Rey Complex Figure Test was found in the treatment groups. Clinical changes, use of concomitant medications, and the emergence of motor side effects did not significantly account for cognitive changes over time. Conclusions: Haloperidol, olanzapine, and risperidone were equally effective in treating cognitive deficits of psychosis. The effect of practice clearly contributes to cognitive score improvements after treatment with antipsychotics. Our results provide important information regarding the practical utility of antipsychotic treatments to improve cognition and could have implications for developing novel approaches for cognitive pharmacotherapy in schizophrenia. J Clin Psychiatry 2009;70(5):717-729 (C) Copyright 2009 Physicians Postgraduate Press, Inc.
引用
收藏
页码:717 / 729
页数:13
相关论文
共 50 条
  • [1] NEUROCOGNITIVE EFFECTIVENESS OF HALOPERIDOL, RISPERIDONE AND OLANZAPINE IN FIRST EPISODE PSYCHOSIS: A RANDOMIZED, CONTROLLED ONE-YEAR FOLLOW-UP COMPARISON
    Crespo-Facorro, Benedicto
    Rodriguez-Sanchez, J.
    Perez-Iglesias, R.
    Mata, I.
    Ayesa, R.
    Ramirez, M.
    Martinez, O.
    Vazquez-Barquero, J.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 352 - 353
  • [2] Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine
    Crespo-Facorro, Benedicto
    Perez-Iglesias, Rocio
    Mata, Ignacio
    Caseiro, Olalla
    Martinez-Garcia, Obdulia
    Pardo, Gema
    Ramirez-Bonilla, MariLuz
    Maria Pelayo-Teran, Jose
    Vazquez-Barquero, Jose L.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (06) : 763 - 769
  • [3] Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison
    Crespo-Facorro, Benedicto
    Perez-Iglesias, Rocio
    Mata, Ignacio
    Ramirez-Bonilla, MariLuz
    Martinez-Garcia, Obdulia
    Pardo-Garcia, Gema
    Caseiro, Olalla
    Pelayo-Teran, Jose Maria
    Vazquez-Barquero, Jose L.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (06) : 744 - 754
  • [4] Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis
    Shim, Joo Cheol
    Choe, Byeong Moo
    Kim, Jung Gee
    Jae, Young Myo
    Kim, Ho Chan
    Kim, Sung Gon
    Kyung, Min
    Kelly, Deanna L.
    Conley, Robert R.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (04) : 400 - 401
  • [5] No decline in neurocognitive functioning from baseline to 1-year follow-up in first-episode psychosis
    Melle, I
    Rund, B
    Friis, S
    Haahr, U
    Johannesen, J
    Larsen, T
    Opjordsmoen, S
    Simonsen, E
    Vaglum, P
    McGlashan, T
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 35 - 35
  • [6] Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
    Ayesa-Arriola, Rosa
    Manuel Rodriguez-Sanchez, Jose
    Perez-Iglesias, Rocio
    Roiz-Santianez, Roberto
    Martinez-Garcia, Obdulia
    Sanchez-Moreno, Jose
    Tabares-Seisdedos, Rafael
    Vazquez-Barquero, Jose L.
    Crespo-Facorro, Benedicto
    PSYCHOPHARMACOLOGY, 2013, 227 (04) : 615 - 625
  • [7] Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone
    Rosa Ayesa-Arriola
    Jose Manuel Rodríguez-Sánchez
    Rocío Pérez-Iglesias
    Roberto Roiz-Santiáñez
    Obdulia Martínez-García
    Jose Sánchez-Moreno
    Rafael Tabarés-Seisdedos
    Jose L. Vázquez-Barquero
    Benedicto Crespo-Facorro
    Psychopharmacology, 2013, 227 : 615 - 625
  • [8] A comparison of the effects of olanzapine, quetiapine, and risperidone on neurocognitive function in first-episode psychosis
    Keefe, R
    Gu, HB
    Perkins, D
    McEvoy, J
    Hamer, R
    Lieberman, J
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S192 - S192
  • [9] Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis
    Cuesta, Manuel J.
    Garcia de Jalon, Elena
    Campos, M. Soledad
    Peralta, Victor
    BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (05) : 439 - 445
  • [10] Experienced Stigma in First-episode Psychosis: A 1-year Follow-up Study
    Simonsen, Carmen
    Faerden, Ann
    Romm, Kristin Lie
    Barrett, Elizabeth Ann
    Ueland, Torill
    Andreassen, Ole
    Melle, Ingrid
    EARLY INTERVENTION IN PSYCHIATRY, 2018, 12 : 128 - 129